After the news story in the Belgium press of two terminally ill cancer patients who used DCA and are now on the road to recovery, the Belgium people are asking questions. "It has brought a lot commotion in Belgium. All the people are wondering why they haven’t heard from DCA any sooner! And they wonder why it isn’t recognized yet as an official medicine for cancer! They are shocked!" (additional Belgium link) (Google-translated English versions 1, 2)

This site is to help inform people of the exciting research done on DCA by scientists at the University of Alberta. In January 2007, a team of scientists at the University of Alberta published a paper in the scientific journal, Cancer Cell, describing the discovery that a simple, cheap molecule, DCA, worked to reactivate the apoptosis mechanism of cancer cells, causing rapid shrinkage of tumors in rats. Mitochondrial reactivation represents an entirely new approach to treating cancer.

The tumors shrank 70% in three weeks.

DCA is not patentable as a molecule. There is no incentive for private companies to spend the millions of dollars needed to get DCA approved as a cancer treatment by the FDA. This is where we, all of us, need to step in. We intend for TheDCAsite.com to be the meeting place, for the world, where all the important information on DCA is gathered and shared.

This site gives the results of the Michelakis research, a look at the possible side effects of DCA and the prospects of it being used by YOU. We have posted the best summaries we can reach on dosages, side effect concerns and additional measures to take to help you fight cancer. Questions are answered and a chat room is provided.

To avoid any legal issues, we must state we are not doctors and cannot give medical advice.

DCA has not been approved by the Food and Drug Administration for the treatment of cancer. It can be prescribed "off-label" by your physician.

Please note that DCA is not active against all cancers. An excellent analysis by "Willis", which is supported by the limited feedback we are getting, indicates that sarcomas, for example, are not controlled by DCA. (Note. sarcoma patients, read this).(head and neck squamous cell patients, click here.) However, many cancers are definitely responding to DCA. Non small cell lung cancer patients, even in Stage 4 are showing good responses. We are seeing lymphatic, bladder and other cancers responding very well to DCA. And recently we are hearing that small cell lung cancers sometimes respond well to DCA.